异常的代谢阻碍了通过药物疗法在骨关节炎中阻碍冠状细胞的建设性代谢
Raquel Largo1, Aranzazu Mediero1, Cristina Villa-Gomez1
1Joint and Bone Research Unit, Service of Rheumatology, IIS Fundación Jiménez Díaz UAM, Madrid, Spain.
Bone & joint research
|March 5, 2025
概括
骨关节炎 (OA) 管理应优先控制炎症,而不是刺激软骨修复. 针对促炎途径为这种致残关节疾病提供了最有前途的治疗策略.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 骨关节炎 (OA) 是一种普遍的,致残的关节疾病,其特点是软骨损失.
- 机械过载和像肥胖这样的代谢因素会通过触发细胞的炎症来加剧OA.
- 目前的OA治疗缺乏有效性,突出显示了尚未满足的治疗需求.
研究的目的:
- 评估炎症在OA发病过程中的作用.
- 评估针对炎症途径与OA治疗的合成刺激的潜在向.
- 确定最有前途的治疗策略来管理OA.
主要方法:
- 对骨关节炎病原体的审查,重点关注机械应激和代谢风险因素.
- 分析冠状细胞对超负荷的反应,包括先天免疫激活.
- 对针对炎症的治疗策略的评估与状细胞合成.
主要成果:
- 机械过载会诱导软骨细胞的炎症反应,导致OA.
- 肥胖和代谢综合征在OA中放大局部和全身炎症.
- 激活状细胞修复的合成药物策略已经显示出有限的有效性.
- 针对OA炎症成分的治疗策略显示出有前途.
结论:
- 控制慢性先天性促炎途径是OA最可行的治疗策略.
- 专注于炎症管理提供了减轻OA症状的最佳机会.
- 未来的OA研究应该优先考虑抗炎方法.
相关概念视频
Overview of Protein Metabolism
667
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
667
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Regulation of Metabolism
9.2K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.2K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K


